In Stock
Vildagliptin Tablets
Vildagliptin 50mg | Anti-Diabetic | Tablets
- Product Form: Raw Powder / API
- Not for direct consumer use
- For qualified buyers, formulation, compounding, R&D, and regulated business use only
- COA/MSDS available upon request
- Final sale depends on buyer country import regulations
Disclaimer: Products listed on this website are intended for qualified business buyers, research, formulation, compounding, or regulated pharmaceutical use only. Products are not intended for direct consumer use. Import permission, registration, customs clearance, and local regulatory compliance are the responsibility of the buyer in their respective country.
Description
Generic name: Vildagliptin 50 mg. Vildagliptin is an oral antidiabetic medicine in the dipeptidyl peptidase-4 (DPP-4) inhibitor class. Important formulation note: “sustained-release” is not a standard formulation description for vildagliptin in many markets. Verify the exact product name, strength and release type on the pack and approved leaflet before using or publishing product-specific instructions. This document summarizes general information about vildagliptin and is not a substitute for professional advice.
Product Introduction
Vildagliptin is used to help improve blood-glucose control in adults with type 2 diabetes, together with diet and physical activity. It inhibits the DPP-4 enzyme, helping the body’s natural incretin hormones regulate insulin and glucagon. Depending on local approval and the patient’s needs, it may be used alone or with other diabetes medicines. The dose and dosing frequency must follow the approved leaflet and a clinician’s directions.
1. Uses
Used to improve blood-glucose control in adults with type 2 diabetes mellitus alongside diet and exercise.
May be prescribed alone or in combination with other antidiabetic medicines when appropriate under local prescribing guidance.
It is not used to treat type 1 diabetes or diabetic ketoacidosis. Do not use it for any condition unless prescribed by a qualified clinician.
2. Benefits
Helps lower blood glucose by supporting the body’s natural incretin response, especially when glucose levels are elevated.
When used with diet, physical activity and regular monitoring, improved glucose control may help reduce the risk of long-term diabetes complications.
When used alone, vildagliptin generally has a low risk of hypoglycaemia; the risk may increase when combined with insulin or a sulfonylurea.
It is generally weight-neutral for many people, although individual results can vary.
Benefits vary by person and depend on the overall treatment plan, other medical conditions, diet, activity and adherence.
3. Side Effects
Possible side effects include:
Headache or dizziness.
Tremor or symptoms of low blood sugar, particularly when combined with insulin or a sulfonylurea.
Nausea or other digestive symptoms in some people.
Joint pain may occur.
Important safety concerns include liver problems and pancreatitis. Seek urgent medical advice for persistent severe abdominal pain, possibly spreading to the back, with or without vomiting; yellowing of the skin or eyes; dark urine; or unusual severe tiredness. Severe allergic symptoms such as facial/throat swelling or difficulty breathing require emergency help.
If low blood sugar is suspected and the person is awake and able to swallow safely, follow the hypoglycaemia plan provided by the healthcare team. If the person is unconscious, having a seizure or unable to swallow, do not give food or drink by mouth—seek emergency medical help.
4. Safety Advice
Use only as prescribed. Do not start, stop or change the dose without consulting your prescriber.
Liver function testing may be required before treatment and periodically during treatment, according to the approved product information. Follow the monitoring schedule provided by your clinician.
Tell your healthcare professional if you have liver disease, kidney problems, a history of pancreatitis, heart failure, or any serious allergy to vildagliptin.
Seek urgent medical assessment if you develop persistent severe abdominal pain or signs of liver problems such as yellowing of the skin or eyes.
If vildagliptin is taken with insulin or a sulfonylurea, low blood sugar may be more likely; your clinician may adjust the other medicine.
Tell your clinician if you are pregnant, planning pregnancy or breastfeeding; treatment may need to be reviewed.
Continue recommended diet, exercise and blood-glucose monitoring. Keep scheduled medical appointments.
Tell your doctor about all medicines, vitamins, supplements and herbal products you use.
Keep out of reach of children and store according to the package instructions.
5. How It Works
Vildagliptin inhibits the DPP-4 enzyme, which normally breaks down incretin hormones such as GLP-1 and GIP. These hormones help the pancreas release insulin when blood glucose is elevated and reduce glucagon release. This helps regulate blood glucose. When used alone, its glucose-dependent action generally means a low risk of hypoglycaemia, although risk can rise when it is combined with certain other diabetes medicines.
6. How to Use
Follow the prescription label and the patient leaflet supplied with the exact product.
Vildagliptin dosing and frequency depend on local approval, kidney and liver function, and other medicines. Do not assume that “50 mg sustained-release” has the same instructions as standard vildagliptin tablets.
Take the tablet with water and follow the leaflet regarding food and timing.
Do not crush, split or chew a modified-release tablet unless the exact product leaflet explicitly permits it.
If you miss a dose, follow the leaflet or ask a pharmacist/doctor. Do not take a double dose to make up for a missed dose.
If you take more than prescribed or suspect an overdose, seek prompt medical advice.
Do not stop treatment because you feel well; discuss any change with your clinician.
7. Quick Tips
Check the pack and approved leaflet to confirm the exact formulation and dose before use.
Take the medicine consistently as prescribed and monitor blood glucose and HbA1c as advised.
Know the symptoms of low blood sugar, especially if you also use insulin or a sulfonylurea.
Attend liver-function and other monitoring appointments recommended by your clinician.
Seek urgent assessment for severe persistent abdominal pain, yellowing of the skin/eyes or serious allergic symptoms.
Tell your healthcare professional before starting any new prescription, over-the-counter medicine, supplement or herbal product.
Continue your recommended diet and physical activity plan. Do not share your medicine with anyone else.
8. Drug Interactions
Your healthcare professional should review your full medication list because other medicines may affect glucose control, safety monitoring or the suitability of treatment.
Insulin and sulfonylureas (such as glimepiride or gliclazide): may increase the risk of hypoglycaemia when used with vildagliptin; the clinician may need to adjust doses.
Some medicines that affect liver enzymes may alter vildagliptin exposure; provide your prescriber with a full medication list.
Other diabetes medicines: combinations may be appropriate but should be directed and monitored by a clinician.
Tell your prescriber about all prescription medicines, over-the-counter products, supplements and herbal products.
Do not start, stop or change any medicine without professional advice.
| Product Name | Vildagliptin Tablets |
| Category | All Medicines, Anti Diabetic |
| Form | Raw Powder |
| Grade | As per available specification |
| Documents | COA, MSDS, Invoice, Packing List |
| Packing | As per order quantity |
| MOQ | On request |
| Shipment | Air cargo / courier / buyer-approved route |
| Use | B2B, formulation, compounding, research & qualified buyer supply |
| Disclaimer | Subject to buyer country regulations |
Additional information
| Strength | 50mg |
|---|---|
| Type | Single API |
| Form | Tablets |
Customer Reviews
Only logged in customers who have purchased this product may leave a review.
